(Q33855392)

29 July 2017

1 reference

title

Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? (English)

1 reference

29 July 2017

0 references

Light GA

1

1 reference

PubMed ID

10704957

29 July 2017

Braff DL

series ordinal

2

1 reference

PubMed ID

10704957

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

Biological Psychiatry

1 reference

29 July 2017

47

1 reference

29 July 2017

5

1 reference

29 July 2017

463-467

1 reference

Lack of relationship of auditory gating defects to negative symptoms in schizophrenia

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Awareness of illness in schizophrenia and schizoaffective and mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Assessment of insight in psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Changes in auditory P3 event-related potential in schizophrenia and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Structured Interview for Assessing Perceptual Anomalies (SIAPA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Delusions: A Review and Integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

An information processing model for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Flexible System for the Diagnosis of Schizophrenia: Report from the WHO International Pilot Study of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

ERPs in schizophrenia: effects of antipsychotic medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Abnormalities of auditory event-related potentials in schizophrenia prior to treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Is P50 suppression a measure of sensory gating in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Disorders of attention and perception in early schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

When metacognition fails: impaired awareness of deficit in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Unawareness of deficits in neuropsychological syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Gating of auditory P50 in schizophrenics: unique effects of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Effects of clozapine on awareness of illness and cognition in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

An overview of current concepts of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

A systematic investigation of tardive dyskinesia in inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Drug refusal in schizophrenia and the wish to be crazy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

Unawareness of illness and neuropsychological performance in chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900280-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00280-2

1 reference

29 July 2017

1 reference

PubMed ID

10704957